Ligandal

Ligandal is developing next-generation precision gene nanomedicine and delivery technologies for gene editing, gene therapy, and regenerative medicine. The company utilizes computational biology, machine learning, artificial intelligence, and new platforms for cell-specific and tissue-specific delivery alongside next-generation nanomaterials. Ligandal develops peptide-based technologies for gene therapy, gene editing, regenerative medicine, immunotherapy, and advanced antidote vaccine technologies, leveraging computational biology approaches to predictively generate methods for delivery and modulation across various disease states.